{ "labelLang" : "hun", "responseDate" : "2024-03-29 10:07", "content" : { "otype" : "JournalArticle", "mtid" : 31259809, "status" : "VALIDATED", "published" : true, "comment" : "Pharmacy Services, Tom Baker Cancer Centre, Alberta Health Services, Edmonton, AB, Canada \n Departments of Oncology and Medicine, University of Calgary and Tom Baker Cancer Centre, Alberta Health Services, 1331-29th Street NW, Calgary, AB T2N4N2, Canada \n Export Date: 15 June 2020 \n CODEN: CPKND \n Correspondence Address: Stewart, D.; Departments of Oncology and Medicine, University of Calgary and Tom Baker Cancer Centre, Alberta Health Services, 1331-29th Street NW, Canada; email: douglas.stewart@ahs.ca \n Chemicals/CAS: bendamustine, 16506-27-7, 3543-75-7; bortezomib, 179324-69-7, 197730-97-5; clotiazepam, 33671-46-4; cyclophosphamide, 50-18-0; doxorubicin, 23214-92-8, 25316-40-9; etoposide, 33419-42-0, 433304-61-1; ibrutinib, 936563-96-1; idelalisib, 1146702-54-6, 870281-82-6; lenalidomide, 191732-72-6; obinutuzumab, 949142-50-1; rituximab, 174722-31-7; venetoclax, 1257044-40-8; vincristine, 57-22-7", "unhandledTickets" : 0, "deleted" : false, "lastRefresh" : "2023-06-05T15:48:49.556+0000", "lastModified" : "2020-08-04T13:50:41.406+0000", "created" : "2020-03-25T10:57:45.632+0000", "creator" : { "otype" : "Admin", "mtid" : 10071338, "link" : "/api/admin/10071338", "label" : "Molnár-Taga Márta (SE_AOK_1Bel_Onkol_Admin5_MTM, admin)", "familyName" : "Molnár-Taga", "givenName" : "Márta", "published" : true, "snippet" : true }, "lastDuplumOK" : "2023-05-30T21:08:51.224+0000", "lastDuplumSearch" : "2023-05-30T21:08:51.224+0000", "adminApproved" : "2020-08-03T09:46:33.499+0000", "adminApprover" : { "otype" : "Admin", "mtid" : 10063433, "link" : "/api/admin/10063433", "label" : "Buzási Éva (Kaposi Mór Kház 5-ös admin)", "familyName" : "Buzási", "givenName" : "Éva", "published" : true, "oldId" : 10063433, "snippet" : true }, "validated" : "2020-08-04T13:50:41.419+0000", "validator" : { "otype" : "Admin", "mtid" : 10063433, "link" : "/api/admin/10063433", "label" : "Buzási Éva (Kaposi Mór Kház 5-ös admin)", "familyName" : "Buzási", "givenName" : "Éva", "published" : true, "oldId" : 10063433, "snippet" : true }, "tempLockers" : [ { "otype" : "Admin", "mtid" : 10065569, "link" : "/api/admin/10065569", "label" : "Pécsi Éva (MTMT Közp 3, admin)", "familyName" : "Pécsi", "givenName" : "Éva", "published" : true, "snippet" : true } ], "tempLocked" : "2023-06-05T15:04:38.794+0000", "core" : false, "citation" : true, "publicationPending" : false, "type" : { "otype" : "PublicationType", "mtid" : 24, "link" : "/api/publicationtype/24", "label" : "Folyóiratcikk", "code" : 24, "otypeName" : "JournalArticle", "listPosition" : 1, "published" : true, "oldId" : 24, "snippet" : true }, "subType" : { "otype" : "SubType", "mtid" : 1134514, "link" : "/api/subtype/1134514", "label" : "Összefoglaló cikk (Folyóiratcikk)", "name" : "Összefoglaló cikk", "nameEng" : "Survey paper", "docType" : { "otype" : "PublicationType", "mtid" : 24, "link" : "/api/publicationtype/24", "label" : "Folyóiratcikk", "code" : 24, "otypeName" : "JournalArticle", "listPosition" : 1, "published" : true, "oldId" : 24, "snippet" : true }, "listPosition" : 102, "published" : true, "oldId" : 1134514, "snippet" : true }, "category" : { "otype" : "Category", "mtid" : 1, "link" : "/api/category/1", "label" : "Tudományos", "published" : true, "oldId" : 1, "snippet" : true }, "languages" : [ { "otype" : "Language", "mtid" : 10002, "link" : "/api/language/10002", "label" : "Angol", "name" : "Angol", "nameEng" : "English", "published" : true, "oldId" : 2, "snippet" : true } ], "firstAuthor" : "Blosser, Nikki", "authorships" : [ { "otype" : "PersonAuthorship", "mtid" : 91298465, "link" : "/api/authorship/91298465", "label" : "Blosser, Nikki", "listPosition" : 1, "share" : 0.0, "first" : true, "last" : false, "corresponding" : false, "familyName" : "Blosser", "givenName" : "Nikki", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 91298466, "link" : "/api/authorship/91298466", "label" : "Jupp, Jennifer", "listPosition" : 2, "share" : 0.0, "first" : false, "last" : false, "corresponding" : false, "familyName" : "Jupp", "givenName" : "Jennifer", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 91298467, "link" : "/api/authorship/91298467", "label" : "Yau, Patrick", "listPosition" : 3, "share" : 0.0, "first" : false, "last" : false, "corresponding" : false, "familyName" : "Yau", "givenName" : "Patrick", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 91298468, "link" : "/api/authorship/91298468", "label" : "Stewart, Douglas ✉", "listPosition" : 4, "share" : 0.0, "first" : false, "last" : true, "corresponding" : true, "familyName" : "Stewart", "givenName" : "Douglas", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true } ], "title" : "Clinical Pharmacokinetic and Pharmacodynamic Considerations in Treating Non-Hodgkin Lymphoma", "identifiers" : [ { "otype" : "PublicationIdentifier", "mtid" : 16793268, "link" : "/api/publicationidentifier/16793268", "label" : "DOI: 10.1007/s40262-019-00807-8", "source" : { "otype" : "PlainSource", "mtid" : 6, "link" : "/api/publicationsource/6", "label" : "DOI", "type" : { "otype" : "PublicationSourceType", "mtid" : 10001, "link" : "/api/publicationsourcetype/10001", "label" : "DOI", "mayHaveOa" : true, "published" : true, "snippet" : true }, "name" : "DOI", "nameEng" : "DOI", "linkPattern" : "https://doi.org/@@@", "publiclyVisible" : true, "published" : true, "oldId" : 6, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "10.1007/s40262-019-00807-8", "realUrl" : "https://doi.org/10.1007/s40262-019-00807-8", "published" : false, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 16793269, "link" : "/api/publicationidentifier/16793269", "label" : "WoS: 000511564400001", "source" : { "otype" : "PlainSource", "mtid" : 1, "link" : "/api/publicationsource/1", "label" : "WoS", "type" : { "otype" : "PublicationSourceType", "mtid" : 10003, "link" : "/api/publicationsourcetype/10003", "label" : "Indexelő adatbázis", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "WoS", "nameEng" : "WoS", "linkPattern" : "https://www.webofscience.com/wos/woscc/full-record/@@@", "publiclyVisible" : true, "published" : true, "oldId" : 1, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "000511564400001", "realUrl" : "https://www.webofscience.com/wos/woscc/full-record/000511564400001", "published" : false, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 16793277, "link" : "/api/publicationidentifier/16793277", "label" : "Scopus: 85070203450", "source" : { "otype" : "PlainSource", "mtid" : 3, "link" : "/api/publicationsource/3", "label" : "Scopus", "type" : { "otype" : "PublicationSourceType", "mtid" : 10003, "link" : "/api/publicationsourcetype/10003", "label" : "Indexelő adatbázis", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "Scopus", "linkPattern" : "http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@", "publiclyVisible" : true, "published" : true, "oldId" : 3, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "85070203450", "realUrl" : "http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85070203450", "published" : false, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 16793270, "link" : "/api/publicationidentifier/16793270", "label" : "PubMed: 31385204", "source" : { "otype" : "PlainSource", "mtid" : 17, "link" : "/api/publicationsource/17", "label" : "PubMed", "type" : { "otype" : "PublicationSourceType", "mtid" : 10003, "link" : "/api/publicationsourcetype/10003", "label" : "Indexelő adatbázis", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "PubMed", "nameEng" : "PubMed", "linkPattern" : "http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract", "publiclyVisible" : true, "published" : true, "oldId" : 17, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "31385204", "realUrl" : "http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=31385204&dopt=Abstract", "published" : false, "snippet" : true } ], "journal" : { "otype" : "Journal", "mtid" : 1077, "link" : "/api/journal/1077", "label" : "CLINICAL PHARMACOKINETICS 0312-5963 1179-1926", "pIssn" : "0312-5963", "eIssn" : "1179-1926", "reviewType" : "REVIEWED", "noIF" : false, "sciIndexed" : true, "scopusIndexed" : true, "lang" : "FOREIGN", "hungarian" : false, "published" : true, "oldId" : 1077, "snippet" : true }, "volume" : "59", "issue" : "1", "firstPage" : "7", "lastPage" : "23", "firstPageOrInternalIdForSort" : "7", "pageLength" : 17, "publishedYear" : 2020, "abstractText" : "Non-Hodgkin lymphoma (NHL) includes a variety of closely related malignancies that originate from lymphoid precursors. The majority of NHLs are of B-cell lineage, for which traditional therapy involves chemotherapy in combination with the anti-CD20 monoclonal antibody rituximab. Ongoing research into the pathogenesis of NHL subtypes has given rise to the use of novel agents that target specific molecular pathways. While the incidence of NHL extends over a range of ages from pediatric to elderly settings, the majority of diagnoses occur over age 60 years. Increasing the use of concomitant medication coupled with declining organ function among this group of patients creates pharmacokinetic (PK) challenges in administering a number of agents involved in the treatment of NHL. In addition, since many of the new agents are administered orally, there are a number of added PK factors that must be taken into consideration with their prescribing and administration. This article will review the available literature on the PK and pharmacodynamic properties of agents commonly used in the treatment of NHL, and intends to provide information that can assist with properly using these drugs in this setting.", "keywords" : [ { "otype" : "Keyword", "mtid" : 19312, "link" : "/api/keyword/19312", "label" : "B-CELL LYMPHOMA", "published" : true, "oldId" : 19312, "snippet" : true }, { "otype" : "Keyword", "mtid" : 19319, "link" : "/api/keyword/19319", "label" : "CHRONIC LYMPHOCYTIC-LEUKEMIA", "published" : true, "oldId" : 19319, "snippet" : true }, { "otype" : "Keyword", "mtid" : 1052060, "link" : "/api/keyword/1052060", "label" : "tyrosine kinase inhibitor", "published" : true, "oldId" : 1052060, "snippet" : true }, { "otype" : "Keyword", "mtid" : 1119581, "link" : "/api/keyword/1119581", "label" : "PHASE-II", "published" : true, "oldId" : 1119581, "snippet" : true }, { "otype" : "Keyword", "mtid" : 1163442, "link" : "/api/keyword/1163442", "label" : "ADVANCED SOLID TUMORS", "published" : true, "oldId" : 1163442, "snippet" : true }, { "otype" : "Keyword", "mtid" : 2000863, "link" : "/api/keyword/2000863", "label" : "ANTI-CD20 MONOCLONAL-ANTIBODY", "published" : true, "snippet" : true }, { "otype" : "Keyword", "mtid" : 2002128, "link" : "/api/keyword/2002128", "label" : "FC-GAMMA-RIIIA", "published" : true, "snippet" : true }, { "otype" : "Keyword", "mtid" : 2002129, "link" : "/api/keyword/2002129", "label" : "PROTEASOME INHIBITOR BORTEZOMIB", "published" : true, "snippet" : true }, { "otype" : "Keyword", "mtid" : 2002130, "link" : "/api/keyword/2002130", "label" : "NATIONAL-CANCER-INSTITUTE", "published" : true, "snippet" : true } ], "digital" : false, "printed" : null, "collaboration" : "INTERNATIONAL", "sourceYear" : 2020, "foreignEdition" : true, "foreignLanguage" : true, "fullPublication" : true, "conferencePublication" : false, "nationalOrigin" : false, "missingAuthor" : false, "oaType" : "NONE", "oaCheckDate" : "2023-06-05", "oaFree" : false, "citationCount" : 0, "citationCountUnpublished" : 0, "citationCountWoOther" : 0, "independentCitCountWoOther" : 0, "doiCitationCount" : 0, "wosCitationCount" : 0, "scopusCitationCount" : 0, "independentCitationCount" : 0, "unhandledCitationCount" : 0, "citingPubCount" : 0, "independentCitingPubCount" : 0, "unhandledCitingPubCount" : 0, "citedPubCount" : 3, "citedCount" : 3, "ratings" : [ { "otype" : "SjrRating", "mtid" : 10873780, "link" : "/api/sjrrating/10873780", "label" : "sjr:Q1 (2020) Scopus - Pharmacology (medical) CLINICAL PHARMACOKINETICS 0312-5963", "listPos" : 25, "rankValue" : 0.24, "type" : "journal", "ratingType" : { "otype" : "RatingType", "mtid" : 10002, "link" : "/api/ratingtype/10002", "label" : "sjr", "code" : "sjr", "published" : true, "snippet" : true }, "subject" : { "otype" : "ClassificationExternal", "mtid" : 2736, "link" : "/api/classificationexternal/2736", "label" : "Scopus - Pharmacology (medical)", "published" : true, "oldId" : 2736, "snippet" : true }, "ranking" : "Q1", "calculation" : "DIRECT", "published" : true, "snippet" : true } ], "ratingsForSort" : "Q1", "referenceList" : "Aapro MS, 2010, ANN ONCOL, V21, P2316, DOI 10.1093/annonc/mdq149 \n Adams J, 2004, CANCER CELL, V5, P417, DOI 10.1016/S1535-6108(04)00120-5 \n Advani RH, 2013, J CLIN ONCOL, V31, P88, DOI 10.1200/JCO.2012.42.7906 \n Agarwal SK, 2017, BRIT J CLIN PHARMACO, V83, P846, DOI 10.1111/bcp.13175 \n Agarwal SK, 2016, J CLIN PHARMACOL, V56, P1335, DOI 10.1002/jcph.730 \n [Anonymous], 2019, KEY STAT NONH LYMPH \n [Anonymous], 2018, VELC BORT PROD MON \n [Anonymous], 2018, ZYD ID PROD MON \n [Anonymous], 2018, FDA APPR 1 BIOS TREA \n [Anonymous], 2018, VENCL VEN PROD MON \n [Anonymous], 2014, DOX PROD MON \n [Anonymous], 2019, RIT RIT PROD MON \n [Anonymous], 2015, ET PROD MON \n [Anonymous], 2012, PROC CYCL PROD MON \n [Anonymous], 2018, TREAND BEND PROD MON \n [Anonymous], 2018, REVL LEN PROD MON \n [Anonymous], 2018, IMBR IBR PROD MON \n Berinstein NL, 1998, ANN ONCOL, V9, P995, DOI 10.1023/A:1008416911099 \n Boross P, 2012, AM J CANCER RES, V2, P676 \n Bubalo JS, 2007, J CLIN ONCOL, V25 \n Buggy JJ, 2012, INT REV IMMUNOL, V31, P119, DOI 10.3109/08830185.2012.664797 \n Cartron G, 2002, BLOOD, V99, P754, DOI 10.1182/blood.V99.3.754 \n Cartron G, 2007, CRIT REV ONCOL HEMAT, V62, P43, DOI 10.1016/j.critrevonc.2006.09.004 \n Cartron G, 2016, HAEMATOLOGICA, V101, P226, DOI 10.3324/haematol.2015.133421 \n Chen CI, 2007, J CLIN ONCOL, V25, P1570, DOI 10.1200/JCO.2006.07.8659 \n Chen NH, 2017, CLIN PHARMACOKINET, V56, P139, DOI 10.1007/s40262-016-0432-1 \n Chen NH, 2010, J CLIN PHARMACOL, V50, P767, DOI 10.1177/0091270009355157 \n Cheson BD, 2018, J CLIN ONCOL, V36, P2259, DOI 10.1200/JCO.2017.76.3656 \n Chiney MS, 2018, XENOBIOTICA, V48, P904, DOI 10.1080/00498254.2017.1381779 \n Coiffier B, 2017, EXPERT REV CLIN PHAR, V10, P923, DOI 10.1080/17512433.2017.1359537 \n Cyclophosphamide, 2013, CYCL BC CANC AG DRUG \n Dall'Ozzo S, 2004, CANCER RES, V64, P4664, DOI 10.1158/0008-5472.CAN-03-2862 \n Davids MS, 2017, J CLIN ONCOL, V35, P826, DOI 10.1200/JCO.2016.70.4320 \n Davies A, 2017, LANCET HAEMATOL, V4, pE272, DOI 10.1016/S2352-3026(17)30078-9 \n Davies A, 2015, EXPERT REV HEMATOL, V8, P581, DOI 10.1586/17474086.2015.1071663 \n Davies A, 2014, LANCET ONCOL, V15, P343, DOI 10.1016/S1470-2045(14)70005-1 \n Dayde D, 2009, BLOOD, V113, P3765, DOI 10.1182/blood-2008-08-175125 \n de Jong J, 2018, LEUKEMIA LYMPHOMA, V59, P2888, DOI 10.1080/10428194.2018.1460474 \n de Jong J, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.156 \n de Jong J, 2015, CANCER CHEMOTH PHARM, V75, P907, DOI 10.1007/s00280-015-2708-9 \n de Jonga J, 2017, LEUKEMIA LYMPHOMA, V58, P185, DOI 10.1080/10428194.2016.1189548 \n de Jonge ME, 2005, CANCER CHEMOTH PHARM, V56, P370, DOI 10.1007/s00280-005-1005-4 \n de Vos S, 2018, ANN ONCOL, V29, P1932, DOI 10.1093/annonc/mdy256 \n de Vries R, 2016, BRIT J CLIN PHARMACO, V81, P235, DOI 10.1111/bcp.12787 \n de Zwart L, 2016, CLIN PHARMACOL THER, V100, P548, DOI 10.1002/cpt.419 \n Doxorubicin, 2017, DOX BC CANC AG DRUG \n Dreyling M, 2016, LANCET, V387, P770, DOI 10.1016/S0140-6736(15)00667-4 \n Egbelakin A, 2011, PEDIATR BLOOD CANCER, V56, P361, DOI 10.1002/pbc.22845 \n Elefante A, 2010, AM J HEALTH-SYST PH, V67, P713, DOI 10.2146/ajhp090328 \n Etoposide, 2017, ET BC CANC AG DRUG M \n FISHER RI, 1993, NEW ENGL J MED, V328, P1002, DOI 10.1056/NEJM199304083281404 \n Fisher RI, 2006, J CLIN ONCOL, V24, P4867, DOI 10.1200/JCO.2006.07.9665 \n Flinn IW, 2014, BLOOD, V123, P3406, DOI 10.1182/blood-2013-11-538546 \n Freise KJ, 2018, EUR J CLIN PHARMACOL, V74, P413, DOI 10.1007/s00228-017-2403-3 \n Friedberg JW, 2011, BLOOD, V117, P2807, DOI 10.1182/blood-2010-11-314708 \n Garattini S, 2007, EUR J CANCER, V43, P271, DOI 10.1016/j.ejca.2006.10.015 \n Gibiansky E, 2014, CPT-PHARMACOMET SYST, V3, DOI 10.1038/psp.2014.42 \n Gilead Sciences Inc, 2014, ZYD ID US PRESCR INF \n Goede V, 2015, BLOOD, V126, DOI 10.1182/blood.V126.23.1733.1733 \n Golay J, 2013, MABS-AUSTIN, V5, P826, DOI 10.4161/mabs.26008 \n Gopal AK, 2014, NEW ENGL J MED, V370, P1008, DOI 10.1056/NEJMoa1314583 \n Gordan LN, 2005, J CLIN ONCOL, V23, P1096, DOI 10.1200/JCO.2005.12.171 \n Gota V, 2016, CANCER CHEMOTH PHARM, V78, P353, DOI 10.1007/s00280-016-3083-x \n Goy A, 2015, BRIT J HAEMATOL, V170, P496, DOI 10.1111/bjh.13456 \n Griggs JJ, 2012, J CLIN ONCOL, V30, P1553, DOI 10.1200/JCO.2011.39.9436 \n Han PY, 2007, CLIN PHARMACOL THER, V82, P505, DOI 10.1038/sj.clpt.6100381 \n Hanley MJ, 2010, CLIN PHARMACOKINET, V49, P71, DOI 10.2165/11318100-000000000-00000 \n Hellmann A, 2011, CLIN PHARMACOKINET, V50, P781, DOI 10.2165/11594410-000000000-00000 \n Herter S, 2013, MOL CANCER THER, V12, P2031, DOI 10.1158/1535-7163.MCT-12-1182 \n Hughes JH, 2019, BRIT J CLIN PHARMACO, V85, P924, DOI 10.1111/bcp.13873 \n Jager U, 2012, HAEMATOL-HEMATOL J, V97, P1431, DOI 10.3324/haematol.2011.059246 \n Jin F, 2015, CANCER CHEMOTH PHARM, V76, P1133, DOI 10.1007/s00280-015-2898-1 \n Jin F, 2016, CANCER CHEMOTH PHARM, V77, P89, DOI 10.1007/s00280-015-2891-8 \n Jin F, 2015, J CLIN PHARMACOL, V55, P944, DOI 10.1002/jcph.504 \n Jin F, 2015, J CLIN PHARMACOL, V55, P909, DOI 10.1002/jcph.495 \n Jin F, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.5575.5575 \n Jin F, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.5570.5570 \n Johnson SA, 1998, BLOOD REV, V12, P52, DOI 10.1016/S0268-960X(98)90030-3 \n Jones AK, 2016, AAPS J, V18, P1192, DOI 10.1208/s12248-016-9927-9 \n Kahl BS, 2007, BLOOD, V110, p1002A, DOI 10.1182/blood.V110.11.3420.3420 \n Keating GM, 2015, TARGET ONCOL, V10, P141, DOI 10.1007/s11523-015-0359-8 \n Kim DH, 2006, BLOOD, V108, P2720, DOI 10.1182/blood-2006-01-009480 \n Koene HR, 1997, BLOOD, V90, P1109, DOI 10.1182/blood.V90.3.1109.1109_1109_1114 \n Kritharis A, 2015, BLOOD, V125, P2471, DOI 10.1182/blood-2014-11-567792 \n Krochinsky FP, 2006, BLOOD, V108, P4662 \n Kuppers R, 2005, NAT REV CANCER, V5, P251, DOI 10.1038/nrc1589 \n Labutti J, 2006, CHEM RES TOXICOL, V19, P539, DOI 10.1021/tx050313d \n Leal TB, 2011, CANCER CHEMOTH PHARM, V68, P1439, DOI 10.1007/s00280-011-1637-5 \n Leblond V, 2016, BLOOD, V128, P1321, DOI 10.1182/blood-2016-04-711234 \n Leonard J, 2018, ASH ANN M 2018 SESS \n Leoni LM, 2011, SEMIN HEMATOL, V48, pS4, DOI 10.1053/j.seminhematol.2011.03.002 \n Leoni LM, 2011, SEMIN HEMATOL, V48, pS12, DOI 10.1053/j.seminhematol.2011.03.003 \n Liu H, 2017, DRUG METAB DISPOS, V45, P294, DOI 10.1124/dmd.116.071613 \n Liu SD, 2015, CANCER IMMUNOL RES, V3, P173, DOI 10.1158/2326-6066.CIR-14-0125 \n LoRusso PM, 2012, CLIN CANCER RES, V18, P2954, DOI 10.1158/1078-0432.CCR-11-2873 \n Lugtenburg P, 2017, HAEMATOLOGICA, V102, P1913, DOI 10.3324/haematol.2017.173583 \n Macagno ALM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028893 \n Manches O, 2003, BLOOD, V101, P949, DOI 10.1182/blood-2002-02-0469 \n Marcus RE, 2016, AM SOC HEM ANN M 3 6 \n Marostica E, 2015, CANCER CHEMOTH PHARM, V75, P111, DOI 10.1007/s00280-014-2617-3 \n McLaughlin P, 1998, J CLIN ONCOL, V16, P2825, DOI 10.1200/JCO.1998.16.8.2825 \n MOORE MJ, 1991, CLIN PHARMACOKINET, V20, P194, DOI 10.2165/00003088-199120030-00002 \n Moreau P, 2012, CLIN PHARMACOKINET, V51, P823, DOI 10.1007/s40262-012-0010-0 \n Morita TO, 2016, J ONCOL PHARM PRACT, V22, P579, DOI 10.1177/1078155215593623 \n Morschhauser F, 2018, NEW ENGL J MED, V379, P934, DOI 10.1056/NEJMoa1805104 \n Muller C, 2012, BLOOD, V119, P3276, DOI 10.1182/blood-2011-09-380949 \n Murawski N, 2014, ANN ONCOL, V25, P1800, DOI 10.1093/annonc/mdu208 \n Niitsu N, 1999, DRUG AGING, V14, P447, DOI 10.2165/00002512-199914060-00005 \n Nowakowski GS, 2016, FUTURE ONCOL, V12, P1553, DOI 10.2217/fon-2016-0130 \n Nowakowski GS, 2015, J CLIN ONCOL, V33, P251, DOI 10.1200/JCO.2014.55.5714 \n O'Brien S, 2018, CL LYMPH MYELOM LEUK, V18, P648, DOI 10.1016/j.clml.2018.06.016 \n Papandreou CN, 2004, J CLIN ONCOL, V22, P2108, DOI 10.1200/JCO.2004.02.106 \n Pfreundschuh M, 2004, BLOOD, V104, P626, DOI 10.1182/blood-2003-06-2094 \n Pfreundschuh M, 2017, BRIT J HAEMATOL, V179, P410, DOI 10.1111/bjh.14860 \n Pfreundschuh M, 2014, J CLIN ONCOL, V32, P4127, DOI 10.1200/JCO.2013.54.6861 \n Pfreundschuh M, 2014, BLOOD, V123, P640, DOI 10.1182/blood-2013-07-517037 \n Quinn DI, 2009, CLIN PHARMACOKINET, V48, P199, DOI 10.2165/00003088-200948030-00006 \n Ramanathan S, 2016, CLIN PHARMACOKINET, V55, P33, DOI 10.1007/s40262-015-0304-0 \n Ramsay AG, 2009, BLOOD, V114, P4713, DOI 10.1182/blood-2009-04-217687 \n Reece DE, 2011, CANCER CHEMOTH PHARM, V67, P57, DOI 10.1007/s00280-010-1283-3 \n Robak T, 2018, LANCET ONCOL, V19, P1449, DOI 10.1016/S1470-2045(18)30685-5 \n Roberts AW, 2016, NEW ENGL J MED, V374, P311, DOI 10.1056/NEJMoa1513257 \n Rubenstein JL, 2018, BLOOD ADV, V2, P1595, DOI 10.1182/bloodadvances.2017014845 \n Rummel M, 2017, ANN ONCOL, V28, P836, DOI 10.1093/annonc/mdw685 \n Rummel MJ, 2011, SEMIN HEMATOL, V48, pS24, DOI 10.1053/j.seminhematol.2011.03.004 \n Said R, 2017, EXPERT OPIN BIOL TH, V17, P1463, DOI 10.1080/14712598.2017.1377178 \n Said R, 2014, EXPERT OPIN DRUG MET, V10, P483, DOI 10.1517/17425255.2014.885016 \n Salem AH, 2017, CLIN DRUG INVEST, V37, P303, DOI 10.1007/s40261-016-0485-9 \n Salem AH, 2016, J CLIN PHARMACOL, V56, P1355, DOI 10.1002/jcph.741 \n Salles G, 2011, LANCET, V377, P42, DOI 10.1016/S0140-6736(10)62175-7 \n Perez-Blanco JS, 2016, BRIT J CLIN PHARMACO, V82, P1517, DOI 10.1111/bcp.13070 \n Sawalha Y, 2016, SCI P, V3, pe1463 \n Schwartz Rowena, 2004, Oncology (Williston Park), V18, P14 \n Smith SM, 2017, LANCET HAEMATOL, V4, pE176, DOI 10.1016/S2352-3026(17)30028-5 \n Tan CRC, 2019, CLIN PHARMACOKINET, V58, P157, DOI 10.1007/s40262-018-0679-9 \n Tout M, 2017, BLOOD, V129, P2616, DOI 10.1182/blood-2016-10-744292 \n Treon SP, 2009, J CLIN ONCOL, V27, P3830, DOI 10.1200/JCO.2008.20.4677 \n Uttamsingh V, 2005, DRUG METAB DISPOS, V33, P1723, DOI 10.1124/dmd.105.005710 \n Venkatakrishnan K, 2009, CLIN THER, V31, P2444, DOI 10.1016/j.clinthera.2009.11.012 \n Vincristine, 2008, VINCR BC CANC AG DRU \n Vitolo U, 2017, J CLIN ONCOL, V35, P3529, DOI 10.1200/JCO.2017.73.3402 \n Wang M, 2013, LEUKEMIA, V27, P1902, DOI 10.1038/leu.2013.95 \n Wang ML, 2013, NEW ENGL J MED, V369, P507, DOI 10.1056/NEJMoa1306220 \n Wasil T, 2005, ONCOLOGIST, V10, P602, DOI 10.1634/theoncologist.10-8-602 \n Webb HK, 2010, ASH ANN M, V116, P1774 \n Wu JM, 1997, J CLIN INVEST, V100, P1059, DOI 10.1172/JCI119616 \n Yuan T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177950 \n Zamorano JL, 2016, EUR HEART J, V37, P2768, DOI 10.1093/eurheartj/ehw211 \n Zinzani PL, 2018, BLOOD, V132, P1614", "hasCitationDuplums" : false, "userChangeableUntil" : "2020-06-23T10:25:25.389+0000", "directInstitutesForSort" : "", "ownerAuthorCount" : 4, "ownerInstituteCount" : 14, "directInstituteCount" : 0, "authorCount" : 4, "contributorCount" : 0, "hasQualityFactor" : true, "tempLockerIds" : [ 10065569 ], "link" : "/api/publication/31259809", "label" : "Blosser Nikki et al. Clinical Pharmacokinetic and Pharmacodynamic Considerations in Treating Non-Hodgkin Lymphoma. (2020) CLINICAL PHARMACOKINETICS 0312-5963 1179-1926 59 1 7-23", "template" : "